| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $3.57B | - | |
| 10% | 33.65M | $1.06B | - | |
| Pres | 18.68M | $588.72M | - | |
| CEO | 16.74M | $527.52M | - | |
| Dir | 15.35M | $483.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 10,000,000 | $1.00 | $10,000,000.00 | +11.2% | |
| Oct 1, 2018 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 2,678,571 | $14.00 | $37,499,994.00 | +13.4% | |
| Jun 5, 2018 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 14,285,714 | $1.75 | $24,999,999.50 | +19.0% | |
| Apr 2, 2018 | Roivant Sciences Ltd.78 | 10% Owner | Buy | 1,110,015 | $20.27 | $22,500,004.05 | +3.0% |